Inner Mongolia Furui Medical Science Co., Ltd. (SZSE: 300049)
Health Care · Pharmaceuticals · CN
CN¥47.11
+0.19% today · -35.2% 1Y
Inner Mongolia Furui Medical Science Co., Ltd. (SZSE: 300049) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.85B and employs 946 people.
Over the last twelve months the share price has lost 35.2%, trading between 36.50 and 86.90.
Tweenvest scores Inner Mongolia Furui Medical Science Co., Ltd. across four factors: quality 79/100, value 49/100, growth 77/100, dividend 6/100. Its strongest factor is quality.
300049 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.85B
- Revenue (TTM)
- $240.96M
- P/E
- 76.31
- EPS
- 0.62
- Dividend yield
- 0.03%
- Beta (5Y)
- -0.31
- 52-week high
- CN¥86.90
- 52-week low
- CN¥36.50
- Avg volume (3M)
- —
- Shares outstanding
- 263.99M
- Employees
- 946
- Next earnings
- —
About Inner Mongolia Furui Medical Science Co., Ltd.
Inner Mongolia Furui Medical Science Co., Ltd. functions as a dedicated platform offering specialized healthcare services. The company's primary focus lies in the liver disease sector, where it delivers a full spectrum of solutions encompassing accurate disease diagnosis, pharmaceutical treatments, and ongoing chronic condition management. Beyond this, it also provides comprehensive health management facilities and general medical care services. Established in 1998, with its headquarters situated in Beijing, China, the entity was previously known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company.
- ISIN
- CNE100000KG1
- Founded
- 1998
- Listed since
- Jan 20, 2010
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shenyang Xingqi Pharmaceutical Co.,Ltd.SZSE: 300573 | $1.90B | CN¥35.66 | -2.11% |
| The United Laboratories International Holdings LimitedSEHK: 3933 | $1.89B | HK$7.51 | -1.31% |
| Beijing Aosaikang Pharmaceutical Co., Ltd.SZSE: 002755 | $1.87B | CN¥13.55 | +7.54% |
| Xeris Biopharma Holdings, Inc.NasdaqGS: XERS | $1.86B | $10.19 | +0.79% |
| PT Kalbe Farma Tbk.IDX: KLBF | $1.83B | Rp725.00 | -1.36% |
| Trevi Therapeutics, Inc.NasdaqGM: TRVI | $1.83B | $12.83 | -2.40% |
| Nuvation Bio Inc.NYSE: NUVB | $1.80B | $4.95 | -3.70% |
| Cohance Lifesciences LimitedNSEI: COHANCE | $1.79B | Rs451.30 | -1.73% |
Figures last refreshed Oct 4, 2026.